Your browser doesn't support javascript.
loading
Synergistic Combination of Irinotecan and Rapamycin Orally Delivered by Nanoemulsion for Enhancing Therapeutic Efficacy of Pancreatic Cancer.
Liu, Yu-Hsuan; Chen, Ling-Chun; Cheng, Wen-Ting; Wei, Pu-Sheng; Hsieh, Chien-Ming; Sheu, Ming-Thau; Lin, Shyr-Yi; Ho, Hsiu-O; Lin, Hong-Liang.
Afiliação
  • Liu YH; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.
  • Chen LC; Department of Biotechnology and Pharmaceutical Technology, Yuanpei University of Medical Technology, Hsinchu 30015, Taiwan.
  • Cheng WT; Department of Biotechnology and Pharmaceutical Technology, Yuanpei University of Medical Technology, Hsinchu 30015, Taiwan.
  • Wei PS; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.
  • Hsieh CM; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.
  • Sheu MT; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.
  • Lin SY; Division of Gastroenterology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.
  • Ho HO; Department of General Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • Lin HL; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.
Pharmaceutics ; 15(2)2023 Jan 31.
Article em En | MEDLINE | ID: mdl-36839795

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Pharmaceutics Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Pharmaceutics Ano de publicação: 2023 Tipo de documento: Article